The Claim
Twelve weeks of daily 12 mg cafestol supplementation significantly lowers gamma-glutamyl transferase (GGT) levels by 15% in healthy adults with increased waist circumference, without affecting liver fat content or LDL cholesterol.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Daily supplementation with 12 mg of cafestol for 12 weeks reduces gamma-glutamyl transferase levels by 15% in healthy adults with increased waist circumference, with no change in liver fat content or LDL cholesterol.
See the scientific wording
Twelve weeks of daily 12 mg cafestol supplementation significantly lowers gamma-glutamyl transferase (GGT) levels by 15% in healthy adults with increased waist circumference, indicating reduced liver stress, without affecting liver fat content or LDL cholesterol.
Cafestol enters the body through the gut, travels to fat tissue around the organs, and reduces the amount of fat stored there. This change lowers stress signals sent to the liver, which then produces less of the enzyme GGT. The liver's fat content stays the same, so the effect is not from removing fat from the liver itself, but from improved signaling due to less belly fat.
What the research says
1 studyThis study gave people with extra belly fat 12 mg of cafestol daily for 12 weeks and found their liver stress marker (GGT) dropped by 15%, without changing their liver fat or bad cholesterol — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.